Houlihan Lokey (NYSE:HLI) PT Raised to $163.00 at Morgan Stanley

Houlihan Lokey (NYSE:HLIGet Free Report) had its price objective raised by investment analysts at Morgan Stanley from $146.00 to $163.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the financial services provider’s stock. Morgan Stanley’s price objective points to a potential upside of 0.65% from the stock’s current price.

A number of other equities research analysts have also recently issued reports on HLI. Wells Fargo & Company started coverage on shares of Houlihan Lokey in a research note on Thursday, September 12th. They issued an “underweight” rating and a $149.00 price target on the stock. JPMorgan Chase & Co. dropped their target price on shares of Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 31st. UBS Group upped their price target on shares of Houlihan Lokey from $157.00 to $170.00 and gave the stock a “buy” rating in a research report on Wednesday, July 31st. Finally, Keefe, Bruyette & Woods reaffirmed a “market perform” rating and issued a $154.00 price target (up from $139.00) on shares of Houlihan Lokey in a research note on Wednesday, July 31st. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Houlihan Lokey currently has an average rating of “Hold” and a consensus target price of $153.00.

View Our Latest Analysis on HLI

Houlihan Lokey Stock Up 0.3 %

HLI stock opened at $161.94 on Monday. Houlihan Lokey has a 52-week low of $94.67 and a 52-week high of $162.63. The firm has a market cap of $11.11 billion, a P/E ratio of 39.40 and a beta of 0.67. The company’s 50-day simple moving average is $151.27 and its 200-day simple moving average is $138.11.

Houlihan Lokey (NYSE:HLIGet Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The financial services provider reported $1.22 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.22. The company had revenue of $514.00 million for the quarter, compared to the consensus estimate of $508.70 million. Houlihan Lokey had a return on equity of 18.80% and a net margin of 15.30%. Houlihan Lokey’s revenue for the quarter was up 23.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.89 earnings per share. On average, analysts anticipate that Houlihan Lokey will post 5.64 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Gillian Beth Zucker sold 200 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $152.28, for a total transaction of $30,456.00. Following the completion of the sale, the director now owns 6,801 shares of the company’s stock, valued at approximately $1,035,656.28. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, Director Gillian Beth Zucker sold 200 shares of Houlihan Lokey stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $152.28, for a total transaction of $30,456.00. Following the transaction, the director now owns 6,801 shares in the company, valued at $1,035,656.28. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, General Counsel Christopher M. Crain sold 1,000 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $155.29, for a total value of $155,290.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 19,619 shares of company stock worth $2,818,759. 25.97% of the stock is owned by insiders.

Institutional Investors Weigh In On Houlihan Lokey

Several hedge funds and other institutional investors have recently bought and sold shares of HLI. Opal Wealth Advisors LLC purchased a new stake in shares of Houlihan Lokey in the 2nd quarter valued at approximately $26,000. Crewe Advisors LLC grew its position in Houlihan Lokey by 264.5% in the second quarter. Crewe Advisors LLC now owns 226 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 164 shares during the period. Ashton Thomas Private Wealth LLC acquired a new stake in Houlihan Lokey during the second quarter worth $38,000. Accent Capital Management LLC purchased a new stake in Houlihan Lokey in the fourth quarter valued at $42,000. Finally, Benjamin F. Edwards & Company Inc. raised its position in Houlihan Lokey by 194.9% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 401 shares of the financial services provider’s stock valued at $52,000 after purchasing an additional 265 shares during the period. 78.07% of the stock is currently owned by institutional investors and hedge funds.

Houlihan Lokey Company Profile

(Get Free Report)

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.

Recommended Stories

Analyst Recommendations for Houlihan Lokey (NYSE:HLI)

Receive News & Ratings for Houlihan Lokey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Houlihan Lokey and related companies with MarketBeat.com's FREE daily email newsletter.